Global Kidney/Renal Fibrosis Treatment Market Report By Type Therapeutics (Angiotensin II Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Pirfenidone, Renin Inhibitors, and Vasopeptidase Inhibitors), By Diagnostic Center (Hospital Testing, Commercial/Private Hospitals, Public Health Hospitals, Clinics, and Home Treatment) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2019-2026
ID:VMR11210051
January 2020
Report Formats:

In the current scenario, the Kidney/Renal Fibrosis Treatment market is an extremely beneficial commercial segment due to the growing number of patients suffering from various types CKD and renal fibrosis. Moreover, increasing government support for developing novel therapies and rising investment in R&D on developing personalized medicine in various private and the public hospital is further propelling the market growth. The advent of the promising drug in the market coupled with the increasing medical expenditure and growing medical tourism rate is another major factor pushing the market growth uphill. Additionally, various recent technological breakthrough such as point-of-care drug delivery systems and penetration of personalized drug is likely to offer opportunity growth to the market over the forecast period.

As per Value Market Report, Kidney/Renal Fibrosis Market is expected to be worth USD 10,486.5 MN by 2024 with a CAGR of 3.5%.
 
ANGIOTENSIN-CONVERTING ENZYME (ACE) TO LEAD THE SEGMENT
It is estimated that ACE Inhibitors will touch USD 3,735.7 MN by end of 2024. The ACE inhibitor is dominating the segment owing to the rising application of a various disorder such as heart, blood vessel, and kidney problems. Basically, this group of drugs causes relaxation of blood vessels as well as a decrease in blood volume, which resulted in lower blood pressure and decreased oxygen demand from the heart. They curb the growth of angiotensin-converting enzyme, an important component of the renin-angiotensin system. Henceforth, this segment is likely to grow on the ground of rising prevalence of various renal disinfections along with the growing population base across the globe.
 
HOSPITAL TESTING TO GAIN THE TRACTION
The hospital testing is accounted for the largest market in 2017. The hospital testing is leading the segment owing to the growing investment in R&D on developing personalized medicine in various private and the public hospital. Also, the rising number of the hospital along with growing healthcare expenditure is another major factor in boosting the growth of the segment.
 
NORTH AMERICA EMERGED AS THE LARGEST MARKET FOR KIDNEY FIBROSIS
North America is accounted for the largest market for kidney fibrosis treatment owing to the presence of a large base of patients suffering from chronic kidney disease (CKD).  Major driving factors raising the growth of this market are the growing base of the population suffering from chronic kidney diseases and high incidence rate of renal fibrosis among the population. Moreover, the development of safe and effective therapeutics for the treatment of kidney fibrosis is contributing to the growth of the regional market.
 
THIS REPORT INCLUDES KEY PLAYERS ALONG WITH THEIR MARKET SHARE
Galectin Therapeutics, Merck & Co., F. Hoffman-La Roche Ltd., Pfizer Inc., InterMune Inc., ProMetic Life-Sciences Inc., La Jolla Pharmaceutical Company, Genzyme Corporation, and BioLine Rx Ltd

As per this study the global kidney/renal fibrosis treatment market was valued USD XXXX.X MN (by revenue) in 2019 and is anticipated to reach USD XXXXX.X MN by 2026 with a CAGR of X.X%.
 
Technically, fibrosis is a biological process which leads to the formation of access fibrous connective tissue in an organ/tissue in a repetitive way. Fibrosis can be a volatile, benign, or pathological state. In response to injury, this is called scarring, and if fibrosis rises from a single cell line, this is called a fibroma. Basically, it is related to the process of scarring. The process is initiated when immune cells such as macrophages release soluble factors that stimulate fibroblasts. Kidney/renal fibrosis may be caused due to disease/infection in the kidney.
 
Market Dynamics
 
The kidney/renal fibrosis treatment market is a highly beneficial market owing to the increasing base of a population suffering from chronic kidney diseases and renal fibrosis. Moreover, increasing government support for developing novel therapies and rising investment in R&D on developing personalized medicine in various private and the public hospital is further propelling the market growth. On the flip side, strict regulatory approvals related to kidney fibrosis therapeutics may limit the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of kidney/renal fibrosis treatment.
 
Market Segmentation
 
The broad kidney/renal fibrosis treatment market has been sub-grouped into therapeutics, and diagnostic center. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Diagnostic Center Market Share 2017
 
Kidney/Renal Fibrosis Treatment Market By Diagnostic Center
 
By Therapeutics

  • Angiotensin II Receptor Blockers (ARBs)
  • Angiotensin Converting Enzyme (ACE) Inhibitors
  • Pirfenidone
  • Renin Inhibitors
  • Vasopeptidase Inhibitors
 
By Diagnostic Center
  • Hospital Testing
  • Commercial/Private Hospitals
  • Public Health Hospitals
  • Clinics
  • Home Treatment
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for kidney/renal fibrosis treatment in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Kidney/Renal Fibrosis Treatment Market By Revenue (USD MN)
 
Europe Kidney/Renal Fibrosis Treatment Market By Revenue
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the kidney/renal fibrosis treatment market includes Merck & Co., F. Hoffman-La Roche Ltd., Pfizer Inc., Galectin Therapeutics, La Jolla Pharmaceutical Company, InterMune Inc., ProMetic Life-Sciences Inc., Genzyme Corporation, and BioLine Rx Ltd. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand. 

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Kidney/Renal Fibrosis Treatment Market
       2.2. Global Kidney/Renal Fibrosis Treatment Market Snapshot
 
3 . KIDNEY/RENAL FIBROSIS TREATMENT – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Kidney/Renal Fibrosis Treatment Market
       3.3. Market Restraints of Kidney/Renal Fibrosis Treatment Market
       3.4. Opportunities of Kidney/Renal Fibrosis Treatment Market
       3.5. Trends of Kidney/Renal Fibrosis Treatment Market
       3.6. Porter’s Five Force Analysis of Kidney/Renal Fibrosis Treatment Market
       3.7. Kidney/Renal Fibrosis Treatment Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Therapeutics
           3.7.2 Market Attractive Analysis by Diagnostic Center
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Kidney/Renal Fibrosis Treatment Value Chain Analysis
       4.2. Kidney/Renal Fibrosis Treatment Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Kidney/Renal Fibrosis Treatment Raw Material Manufactures List
           4.2.3. Price Trend of Kidney/Renal Fibrosis Treatment Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL KIDNEY/RENAL FIBROSIS TREATMENT MARKET ANALYSIS BY THERAPEUTICS
       5.1 Overview by Therapeutics
       5.2 Global Kidney/Renal Fibrosis Treatment Market Analysis by Therapeutics
       5.3 Market Analysis of Angiotensin II Receptor Blockers (ARBs) by Regions
       5.4 Market Analysis of Angiotensin Converting Enzyme (ACE) Inhibitors by Regions
       5.5 Market Analysis of Pirfenidone by Regions
       5.6 Market Analysis of Renin Inhibitors by Regions
       5.7 Market Analysis of Vasopeptidase Inhibitors by Regions
 
6 . GLOBAL KIDNEY/RENAL FIBROSIS TREATMENT MARKET ANALYSIS BY DIAGNOSTIC CENTER
       6.1 Overview by Diagnostic Center
       6.2 Global Kidney/Renal Fibrosis Treatment Market Analysis by Diagnostic Center
       6.3 Market Analysis of Hospital Testing by Regions
       6.4 Market Analysis of Commercial/Private Hospitals by Regions
       6.5 Market Analysis of Public Health Hospitals by Regions
       6.6 Market Analysis of Clinics by Regions
       6.7 Market Analysis of Home Treatment by Regions
 
7 . GLOBAL KIDNEY/RENAL FIBROSIS TREATMENT MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview
           7.3.2. North America Kidney/Renal Fibrosis Treatment Market Estimate by Market Segment
           7.3.3. North America Kidney/Renal Fibrosis Treatment Market Estimate by Country
           7.3.4. United State
           7.3.5. Rest of North America
       7.4. Europe
           7.4.1. Overview
           7.4.2. Europe Kidney/Renal Fibrosis Treatment Market Estimate by Market Segment
           7.4.3. Europe Kidney/Renal Fibrosis Treatment Market Estimate by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7 Rest of Europe
       7.5. Asia Pacific
           7.5.1. Overview
           7.5.2. Asia Pacific Kidney/Renal Fibrosis Treatment Market Estimate by Market Segment
           7.5.3. Asia Pacific Kidney/Renal Fibrosis Treatment Market Estimate by Country
           7.5.4. China
           7.5.5. Japan
           7.5.6. India
           7.5.7. Rest of Asia Pacific
       7.6. Latin America
           7.6.1. Overview
           7.6.2. Latin America Kidney/Renal Fibrosis Treatment Market Estimate by Market Segment
           7.6.3. Latin America Kidney/Renal Fibrosis Treatment Market Estimate by Country
           7.6.4. Brazil
           7.6.5. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview
           7.7.2. Middle East & Africa Kidney/Renal Fibrosis Treatment Market Estimate by Market Segment
           7.7.3. Middle East & Africa Kidney/Renal Fibrosis Treatment Market Estimate by Country
           7.7.4. Middle East
           7.7.5. Africa
 
8 . COMPETITIVE LANDSCAPE OF THE KIDNEY/RENAL FIBROSIS TREATMENT COMPANIES
       8.1. Kidney/Renal Fibrosis Treatment Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments
 
9 . COMPANY PROFILES OF KIDNEY/RENAL FIBROSIS TREATMENT INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. BioLine Rx Ltd.
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. F. Hoffman-La Roche Ltd.
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. Galectin Therapeutics
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. Genzyme Corporation
           9.6.1. Company Overview
           9.6.2. Financials
           9.6.3. Products
           9.6.4. Recent Developments
       9.7. InterMune Inc.
           9.7.1. Company Overview
           9.7.2. Financials
           9.7.3. Products
           9.7.4. Recent Developments
       9.8. La Jolla Pharmaceutical Company
           9.8.1. Company Overview
           9.8.2. Financials
           9.8.3. Products
           9.8.4. Recent Developments
       9.9. Merck & Co.
           9.9.1. Company Overview
           9.9.2. Financials
           9.9.3. Products
           9.9.4. Recent Developments
       9.10. Pfizer Inc.
           9.10.1. Company Overview
           9.10.2. Financials
           9.10.3. Products
           9.10.4. Recent Developments
       9.11. ProMetic Life-Sciences Inc.
           9.11.1. Company Overview
           9.11.2. Financials
           9.11.3. Products
           9.11.4. Recent Developments
 
10.  IMPACT ANALYSIS OF COVID-19 OUTBREAK
       10.1. Impact Analysis of Covid-19 Outbreak on the Market
           10.1.1. Direct Impact on Production
           10.1.2. Supply Chain and Market Disruption
           10.1.3. Financial Impact on Firms and Financial Markets
       10.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       10.3. Pre V/S Post COVID-19 Market
       10.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
       10.5. COVID-19: Micro and Macro Factor Analysis on the Market
    
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  •  Global Market Snapshot
  •  Drivers of the Global Market Impact Analysis
  •  Restraints of the Global Market Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers 
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19 Market
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
  •  COVID-19: Micro and Macro Factor Analysis on the Marketv
  •  Global Kidney/Renal Fibrosis Treatment Market Analysis by Therapeutics (USD MN)
  •  Global Kidney/Renal Fibrosis Treatment Market Analysis in Angiotensin II Receptor Blockers (ARBs) by Geography (USD MN)
  •  Global Kidney/Renal Fibrosis Treatment Market Analysis in Angiotensin Converting Enzyme (ACE) Inhibitors by Geography (USD MN)
  •  Global Kidney/Renal Fibrosis Treatment Market Analysis in Pirfenidone by Geography (USD MN)
  •  Global Kidney/Renal Fibrosis Treatment Market Analysis in Renin Inhibitors by Geography (USD MN)
  •  Global Kidney/Renal Fibrosis Treatment Market Analysis in Vasopeptidase Inhibitors by Geography (USD MN)
  •  Global Kidney/Renal Fibrosis Treatment Market Analysis by Diagnostic Center (USD MN)
  •  Global Kidney/Renal Fibrosis Treatment Market Analysis in Hospital Testing by Geography (USD MN)
  •  Global Kidney/Renal Fibrosis Treatment Market Analysis in Commercial/Private Hospitals by Geography (USD MN)
  •  Global Kidney/Renal Fibrosis Treatment Market Analysis in Public Health Hospitals by Geography (USD MN)
  •  Global Kidney/Renal Fibrosis Treatment Market Analysis in Clinics by Geography (USD MN)
  •  Global Kidney/Renal Fibrosis Treatment Market Analysis in Home Treatment by Geography (USD MN)
  •  Global Kidney/Renal Fibrosis Treatment Market by Geography (USD MN)
  •  North America Kidney/Renal Fibrosis Treatment Market Analysis by Therapeutics (USD MN)
  •  North America Kidney/Renal Fibrosis Treatment Market Estimate by Diagnostic Center (USD MN)
  •  North America Kidney/Renal Fibrosis Treatment Market Estimate by Country (USD MN)
  •  United State Kidney/Renal Fibrosis Treatment Market Analysis by Therapeutics (USD MN)
  •  United State Kidney/Renal Fibrosis Treatment Market Estimate by Diagnostic Center (USD MN)
  •  Rest of North America Kidney/Renal Fibrosis Treatment Market Analysis by Therapeutics (USD MN)
  •  Rest of North America Kidney/Renal Fibrosis Treatment Market Estimate by Diagnostic Center (USD MN)
  •  Europe Kidney/Renal Fibrosis Treatment Market Analysis by Therapeutics (USD MN)
  •  Europe Kidney/Renal Fibrosis Treatment Market Estimate by Diagnostic Center (USD MN)
  •  United Kingdom Kidney/Renal Fibrosis Treatment Market Analysis by Therapeutics (USD MN)
  •  United Kingdom Kidney/Renal Fibrosis Treatment Market Estimate by Diagnostic Center (USD MN)
  •  France Kidney/Renal Fibrosis Treatment Market Analysis by Therapeutics (USD MN)
  •  France Kidney/Renal Fibrosis Treatment Market Estimate by Diagnostic Center (USD MN)
  •  Germany Kidney/Renal Fibrosis Treatment Market Analysis by Therapeutics (USD MN)
  •  Germany Kidney/Renal Fibrosis Treatment Market Estimate by Diagnostic Center (USD MN)
  •  Rest of Europe Kidney/Renal Fibrosis Treatment Market Analysis by Therapeutics (USD MN)
  •  Rest of Europe Kidney/Renal Fibrosis Treatment Market Estimate by Diagnostic Center (USD MN)
  •  Asia Pacific Kidney/Renal Fibrosis Treatment Market Analysis by Therapeutics (USD MN)
  •  Asia Pacific Kidney/Renal Fibrosis Treatment Market Estimate by Diagnostic Center (USD MN)
  •  Asia Pacific Kidney/Renal Fibrosis Treatment Market Estimate by Country (USD MN)
  •  China Kidney/Renal Fibrosis Treatment Market Analysis by Therapeutics (USD MN)
  •  China Kidney/Renal Fibrosis Treatment Market Estimate by Diagnostic Center (USD MN)
  •  Japan Kidney/Renal Fibrosis Treatment Market Analysis by Therapeutics (USD MN)
  •  Japan Kidney/Renal Fibrosis Treatment Market Estimate by Diagnostic Center (USD MN)
  •  India Kidney/Renal Fibrosis Treatment Market Analysis by Therapeutics (USD MN)
  •  India Kidney/Renal Fibrosis Treatment Market Estimate by Diagnostic Center (USD MN)
  •  Rest of Asia Pacific Kidney/Renal Fibrosis Treatment Market Analysis by Therapeutics (USD MN)
  •  Rest of Asia Pacific Kidney/Renal Fibrosis Treatment Market Estimate by Diagnostic Center (USD MN)
  •  Latin America Kidney/Renal Fibrosis Treatment Market Analysis by Therapeutics (USD MN)
  •  Latin America Kidney/Renal Fibrosis Treatment Market Estimate by Diagnostic Center (USD MN)
  •  Latin America Kidney/Renal Fibrosis Treatment Market Estimate by Country (USD MN)
  •  Brazil Kidney/Renal Fibrosis Treatment Market Analysis by Therapeutics (USD MN)
  •  Brazil Kidney/Renal Fibrosis Treatment Market Estimate by Diagnostic Center (USD MN)
  •  Rest of Latin America Kidney/Renal Fibrosis Treatment Market Analysis by Therapeutics (USD MN)
  •  Rest of Latin America Kidney/Renal Fibrosis Treatment Market Estimate by Diagnostic Center (USD MN)
  •  Middle East & Africa Kidney/Renal Fibrosis Treatment Market Analysis by Therapeutics (USD MN)
  •  Middle East & Africa Kidney/Renal Fibrosis Treatment Market Estimate by Diagnostic Center (USD MN)
  •  Middle East & Africa Kidney/Renal Fibrosis Treatment Market Estimate by Country (USD MN)
  •  Middle East Kidney/Renal Fibrosis Treatment Market Analysis by Therapeutics (USD MN)
  •  Middle East Kidney/Renal Fibrosis Treatment Market Estimate by Diagnostic Center (USD MN)
  •  Africa Kidney/Renal Fibrosis Treatment Market Analysis by Therapeutics (USD MN)
  •  Africa Kidney/Renal Fibrosis Treatment Market Estimate by Diagnostic Center (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton
  •  New Product Launch
  •  Other Developments
  •  Company Market Share Analysis, 2019
 
 LIST OF FIGURES
 
  •  Research Scope of Kidney/Renal Fibrosis Treatment Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Kidney/Renal Fibrosis Treatment Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Therapeutics
  •  Market Attractiveness Analysis by Diagnostic Center
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Kidney/Renal Fibrosis Treatment Market Analysis by Therapeutics (USD MN)
  •  Global Kidney/Renal Fibrosis Treatment Market Analysis in Angiotensin II Receptor Blockers (ARBs) by Geography (USD MN)
  •  Global Kidney/Renal Fibrosis Treatment Market Analysis in Angiotensin Converting Enzyme (ACE) Inhibitors by Geography (USD MN)
  •  Global Kidney/Renal Fibrosis Treatment Market Analysis in Pirfenidone by Geography (USD MN)
  •  Global Kidney/Renal Fibrosis Treatment Market Analysis in Renin Inhibitors by Geography (USD MN)
  •  Global Kidney/Renal Fibrosis Treatment Market Analysis in Vasopeptidase Inhibitors by Geography (USD MN)
  •  Global Kidney/Renal Fibrosis Treatment Market Analysis by Diagnostic Center (USD MN)
  •  Global Kidney/Renal Fibrosis Treatment Market Analysis in Hospital Testing by Geography (USD MN)
  •  Global Kidney/Renal Fibrosis Treatment Market Analysis in Commercial/Private Hospitals by Geography (USD MN)
  •  Global Kidney/Renal Fibrosis Treatment Market Analysis in Public Health Hospitals by Geography (USD MN)
  •  Global Kidney/Renal Fibrosis Treatment Market Analysis in Clinics by Geography (USD MN)
  •  Global Kidney/Renal Fibrosis Treatment Market Analysis in Home Treatment by Geography (USD MN)
  •  Latin America Kidney/Renal Fibrosis Treatment Market by Revenue
  •  Middle East & Africa Kidney/Renal Fibrosis Treatment Market by Revenue
  •  Recent Development in Kidney/Renal Fibrosis Treatment Industry
  •  Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials